Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last SFr.97.10 CHF
Change Today +0.10 / 0.10%
Volume 18.7K
YPSN On Other Exchanges
Symbol
Exchange
YPSN is not on other exchanges.
As of 11:43 AM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

ypsomed holding ag-reg (YPSN) Snapshot

Open
SFr.97.25
Previous Close
SFr.97.00
Day High
SFr.97.75
Day Low
SFr.96.85
52 Week High
06/2/15 - SFr.97.75
52 Week Low
01/22/15 - SFr.76.10
Market Cap
1.2B
Average Volume 10 Days
48.6K
EPS TTM
SFr.1.54
Shares Outstanding
12.6M
EX-Date
07/6/15
P/E TM
63.3x
Dividend
SFr.0.60
Dividend Yield
0.31%
Current Stock Chart for YPSOMED HOLDING AG-REG (YPSN)

Related News

No related news articles were found.

ypsomed holding ag-reg (YPSN) Related Businessweek News

No Related Businessweek News Found

ypsomed holding ag-reg (YPSN) Details

Ypsomed Holding AG develops, manufactures, and sells injection pens for pharmaceutical and biotech companies worldwide. The company operates in two segments, Delivery Devices and Diabetes Direct Business. The Delivery Devices segment products include pen systems, pen needles, infusion sets, and other injection moldings products. The Diabetes Direct Business sells and trades devices for the self-monitoring of blood glucose levels, as well as infusion pumps, accessories, and other day-to-day items for diabetics. It offers insulin pumps, injection systems, and pen needles for the treatment of diabetes, growth disorders, infertility, and other therapeutic areas; and pen needles under the mylife Diabetescare brand for the treatment of diabetes. Ypsomed Holding AG markets its products through biotech and pharmaceutical partners, as well as through its own distribution network and independent distributors. The company was founded in 1984 and is headquartered in Burgdorf, Switzerland.

989 Employees
Last Reported Date: 11/7/14
Founded in 1984

ypsomed holding ag-reg (YPSN) Top Compensated Officers

Senior Vice President of Legal & Intellectual...
Total Annual Compensation: SFr.387.0K
Compensation as of Fiscal Year 2014.

ypsomed holding ag-reg (YPSN) Key Developments

Ypsomed Holding AG Proposes Dividend for the Fiscal Year 2015

Ypsomed Holding AG will propose the dividend for the fiscal year 2015 to be doubled to CHF 0.60 per share.

Ypsomed Holding AG Reports Earnings Results for the Fiscal Year Ended March 2015; Provides Earnings Guidance for the Fiscal Year 2016

Ypsomed Holding AG reported earnings results for the fiscal year ended March 2015. For the period, the company’s net profit jumped by 43% to CHF 19.4 million, boosted by the strong sales performance of all units, as well as process and costs optimization. The company noted net profit growth was slowed down by the surge in the Swiss franc and an impairment of CHF 1.7 million related to the company's participation in Bionime. Earnings before interest and tax (EBIT) surged by more than 80% to CHF 28.5 million. Sales amounted to CHF 306.6 million, an increase of 11% on the year. The company announced that it expects sales in fiscal 2016 to grow by around 10%. EBIT is expected to amount to CHF 35 million.

Ypsomed Holding AG Proposes Changes to the Articles of Association

Ypsomed Holding AG proposed changes to the Articles of Association that is approval of the proposed amendments to Art. 13 (previously Art. 16 of the Articles of Association) pursuant to Appendix at its AGM to be held on July 1, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
YPSN:SW SFr.97.10 CHF +0.10

YPSN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Antares Pharma Inc $2.26 USD +0.12
Becton Dickinson and Co $140.51 USD -0.31
Bioject Medical Technologies Inc $0.08 USD -0.007
Terumo Corp ¥2,747 JPY -6.00
West Pharmaceutical Services Inc $54.90 USD +0.20
View Industry Companies
 

Industry Analysis

YPSN

Industry Average

Valuation YPSN Industry Range
Price/Earnings 68.3x
Price/Sales 4.2x
Price/Book 5.3x
Price/Cash Flow 68.4x
TEV/Sales 4.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact YPSOMED HOLDING AG-REG, please visit www.ypsomed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.